#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1054500	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
2.	ALA1054501	F	GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
3.	ALA1054502	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
4.	ALA1054503	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
5.	ALA1054504	F	GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.	Homo sapiens	13,467	ALA1157539	cell-based format	GSK Malaria Screening
6.	ALA1054505	F	GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested		13,467	ALA1157539	assay format	GSK Malaria Screening
7.	ALA1040691	F	NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614	ALA1156829	organism-based format	Novartis Malaria Screening
8.	ALA1040692	F	NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614	ALA1156829	organism-based format	Novartis Malaria Screening
9.	ALA1040693	T	NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)	Homo sapiens	5,614	ALA1156829	cell-based format	Novartis Malaria Screening
10.	ALA1040694	F	NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.		5,614	ALA1156829	assay format	Novartis Malaria Screening
11.	ALA1789905	F	NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.	Plasmodium yoelii	4,416	ALA1789904	organism-based format	Novartis Malaria Screening
12.	ALA1789906	F	NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration	Plasmodium yoelii	338	ALA1789904	organism-based format	Novartis Malaria Screening
13.	ALA2028071	F	MMV: Inhibition of Plasmodium falciparum 3D7 (EC50).	Plasmodium falciparum	317	ALA2028040	organism-based format	MMV Malaria Box
14.	ALA2028073	F	MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro).	Trypanosoma cruzi	400	ALA2028040	organism-based format	MMV Malaria Box
15.	ALA2028074	F	MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro).	Trypanosoma brucei brucei	400	ALA2028040	organism-based format	MMV Malaria Box
16.	ALA2028075	F	MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro).	Trypanosoma brucei rhodesiense	400	ALA2028040	organism-based format	MMV Malaria Box
17.	ALA2028076	F	MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.	Leishmania infantum	400	ALA2028040	organism-based format	MMV Malaria Box
18.	ALA2028077	T	MMV: Cytotoxicity against human fibroblasts (MRC-5) cells.	Homo sapiens	400	ALA2028040	cell-based format	MMV Malaria Box
19.	ALA2094261	F	MMV: Screen against Mtb, single point, non replicating, at 25uM	Mycobacterium tuberculosis	399	ALA2094260	organism-based format	MMV Malaria Box
20.	ALA2094262	F	MMV: Screen against Mtb, single point, replicating, at 25uM	Mycobacterium tuberculosis	399	ALA2094260	organism-based format	MMV Malaria Box